SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-225321
Filing Date
2017-07-10
Accepted
2017-07-10 17:18:03
Documents
4
Period of Report
2017-07-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d313341d8k.htm 8-K 36213
2 EX-99.1 d313341dex991.htm EX-99.1 330900
3 EX-99.2 d313341dex992.htm EX-99.2 56446
4 GRAPHIC g313341page58.jpg GRAPHIC 4124
  Complete submission text file 0001193125-17-225321.txt   430802
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36828 | Film No.: 17958528
SIC: 2834 Pharmaceutical Preparations